IRIS
MICALE, VINCENZO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.723
AS - Asia 1.755
EU - Europa 1.513
SA - Sud America 388
AF - Africa 166
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 1
Totale 7.550
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.570
SG - Singapore 889
CN - Cina 554
IT - Italia 453
IE - Irlanda 359
BR - Brasile 332
RU - Federazione Russa 162
UA - Ucraina 158
CA - Canada 131
CI - Costa d'Avorio 107
VN - Vietnam 94
DE - Germania 61
GB - Regno Unito 58
KR - Corea 58
IN - India 55
ES - Italia 41
SE - Svezia 40
NL - Olanda 34
CZ - Repubblica Ceca 28
FI - Finlandia 28
SN - Senegal 27
PL - Polonia 20
AR - Argentina 17
MX - Messico 16
TR - Turchia 16
FR - Francia 15
JP - Giappone 15
BD - Bangladesh 12
EC - Ecuador 12
ID - Indonesia 11
CH - Svizzera 10
ZA - Sudafrica 10
IQ - Iraq 8
VE - Venezuela 8
AT - Austria 7
BE - Belgio 7
CO - Colombia 7
GR - Grecia 7
LB - Libano 7
NG - Nigeria 7
DK - Danimarca 6
HK - Hong Kong 6
BG - Bulgaria 5
BJ - Benin 5
PK - Pakistan 5
UZ - Uzbekistan 5
AE - Emirati Arabi Uniti 4
EU - Europa 4
IR - Iran 4
AZ - Azerbaigian 3
CL - Cile 3
PE - Perù 3
PY - Paraguay 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
BB - Barbados 2
BO - Bolivia 2
KE - Kenya 2
KZ - Kazakistan 2
LT - Lituania 2
RS - Serbia 2
AL - Albania 1
AU - Australia 1
BH - Bahrain 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
GY - Guiana 1
HN - Honduras 1
HU - Ungheria 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
JO - Giordania 1
LV - Lettonia 1
MA - Marocco 1
MU - Mauritius 1
OM - Oman 1
PS - Palestinian Territory 1
PT - Portogallo 1
RO - Romania 1
SA - Arabia Saudita 1
SM - San Marino 1
TJ - Tagikistan 1
TT - Trinidad e Tobago 1
ZW - Zimbabwe 1
Totale 7.550
Salva come PNG Salva come JPEG
Città #
Santa Clara 758
Dallas 645
Singapore 456
Dublin 341
Chandler 300
Jacksonville 234
Chicago 199
Boardman 139
Hefei 115
Catania 109
Abidjan 107
Cambridge 92
Lawrence 92
Ashburn 91
Andover 90
Nanjing 85
Toronto 82
Los Angeles 67
Des Moines 64
Seoul 58
Beijing 50
Moscow 47
Houston 40
Civitanova Marche 35
Ho Chi Minh City 32
Nanchang 32
Hebei 30
Messina 28
New York 28
Ottawa 28
Dakar 27
Amsterdam 26
São Paulo 26
Hyderabad 25
Rome 25
Saint Petersburg 24
Shenyang 22
Tianjin 22
Changsha 21
Prague 21
Hanoi 20
Munich 20
Jiaxing 19
Council Bluffs 18
San Mateo 18
Wilmington 18
Barcelona 17
Brooklyn 16
Buffalo 14
Tokyo 13
Columbus 12
Lappeenranta 12
The Dalles 12
Warsaw 12
Palermo 10
Poplar 10
Zhengzhou 10
Belo Horizonte 9
Denver 9
Florence 9
Jinan 9
San Francisco 9
Seattle 9
Atlanta 8
Phoenix 8
Abuja 7
Augusta 7
Brussels 7
Dong Ket 7
Johannesburg 7
Manchester 7
Montreal 7
Turku 7
Berlin 6
Boston 6
Chennai 6
Guangzhou 6
Haiphong 6
Helsinki 6
Istanbul 6
Madrid 6
Mumbai 6
Orem 6
Redwood City 6
Rio de Janeiro 6
Aci Catena 5
Bremen 5
Cotonou 5
Foggia 5
Hangzhou 5
Hong Kong 5
London 5
Ningbo 5
Ribeirão Preto 5
Secaucus 5
Stockholm 5
Tübingen 5
Baghdad 4
Biên Hòa 4
Brasília 4
Totale 5.234
Salva come PNG Salva come JPEG
Nome #
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 129
Behavioral and neurochemical changes induced by stress-related conditions are counteracted by the neurokinin-2 receptor antagonist saredutant 114
Altered responses of dopamine D3 receptor null mice to excitotoxic or anxiogenic stimuli: Possible involvement of the endocannabinoid and endovanilloid systems 111
The beta3 adrenoceptor agonist, amibegron (SR58611A) counteracts stress-induced behavioral and neurochemical changes 110
Peripubertal cannabidiol treatment rescues behavioral and neurochemical abnormalities in the MAM model of schizophrenia 109
Are the epigenetic changes predictive of therapeutic efficacy for psychiatric disorders? A translational approach towards novel drug targets 104
Fluoxetine Protects Retinal Ischemic Damage in Mice 102
Behavioral effects of dietary cholesterol in rats tested in experimental models of mild stress and cognition tasks 102
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 102
Crosstalk between the transcriptional regulation of dopamine D2 and cannabinoid CB1 receptors in schizophrenia: analyses in patients and perinatal Δ9-tetrahydrocannabinol-exposed rats 98
Different effects of prenatal MAM vs. perinatal THC exposure on regional cerebral blood perfusion detected by Arterial Spin Labelling MRI in rats 97
Anxiolytic effects in mice of a dual blocker of fatty acid amide hydrolase and transient receptor potential vanilloid type-1 channels 96
Endocannabinoids and beta-amyloid-induced neurotoxicity in vivo: effect of pharmacological elevation of endocannabinoid levels 96
Systemic depletion of histone macroH2A1.1 boosts hippocampal synaptic plasticity and social behavior in mice 96
Altro che Marijuana i molteplici ruoli delle sostanze cannabinoidi endogene 95
Behavioral effects of the β3 adrenoceptor agonist SR58611A: Is it the putative prototype of a new class of antidepressant/anxiolytic drugs? 95
Beavioral effects of SR 58611A, a beta-3 agonist, on experimental models of mild stress 93
Behavioral effects of saredutant, a tachykinin NK2 receptor antagonist, in experimental models of mood disorders under basal and stress-related conditions 93
Antidepressant properties of the 5-HT4 receptor partial agonist, SL65.0155: behavioral and neurochemical studies in rats 92
The Effects of Peripubertal THC Exposure in Neurodevelopmental Rat Models of Psychopathology 91
Retinal pharmacodynamic and pharmacokinetic profile of cannabidiol in an in vivo model of retinal excitotoxicity 91
Amnesia induced by beta-amyloid fragments is counteracted by cannabinoid CB1 receptor blockade 91
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis 90
Amnesia induced by beta-amyloid peptide in dopamine D3 knock-out (KO) mice Is affectedby a cannabinoid CB1 receptor antagonist 90
Endocannabinoids and neurodegenerative diseases 89
Behavioral and molecular effects of repeated treatment with citalopram alone or combined with memantine in rats 85
Early modulation of the endocannabinoid tone prevents molecular and behavioral alterations in MAM model of schizophrenia 85
Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia 85
Attuali orientamenti terapeutici della malattia di Parkinson 84
Behavioral and pharmacokinetic profile of indole-derived synthetic cannabinoids JWH-073 and JWH-210 as compared to the phytocannabinoid 19-THC in rats 84
Behavioral effects of ABIO 09/01, a CaMKII inhibitor, on experimental models of depression and anxiety 83
Behavioral modifications induced by dietary cholesterol in rats 83
The cannabinoid CB1 antagonist TM38837 with limited penetrance to the brain shows reduced fear-promoting effects in mice 83
Melatonin affects the immobility time of rats in the forced swim test: The role of serotonin neurotransmission 82
The selective norepinephrine reuptake inhibitor atomoxetine counteracts behavioral impairments in trimethyltin-intoxicated rats 82
Cannabinoid CB1 receptor blockade effects memory capacity of dopamine D3 KO mice pre-treated with β-amyloid peptide 80
Cannabidiol and the central nervous system: translating into clinics 79
Red Flags in Primary Mitochondrial Diseases: What Should We Recognize? 78
2-AG promotes the expression of conditioned fear via cannabinoid receptor type 1 on GABAergic neurons 77
Effects of citalopram combined with memantine in forced swimming test in rats 74
Phytocannabinoids and schizophrenia: Focus on adolescence as a critical window of enhanced vulnerability and opportunity for treatment 73
Dopamine D(3) receptor knock-out mice exhibit increased behavioral sensitivity to the anxiolytic drug diazepam 72
Therapeutic potential of cannabinoids in schizophrenia 72
Reactivity to addictive drugs in the methylazoxymethanol (MAM) model of schizophrenia in male and female rats 70
“Prescription pattern of antiepileptics in primary care in Italy upon recognition of new indications for reimbursement“. 70
Long-lasting neurotoxicity of prenatal benzene acute exposure in rats 69
Cognitive effects of SL65.0155, a serotonin 5-HT4 receptor partial agonist, in animal models of amnesia 69
Sex Differences in the Reinstatement of Methamphetamine Seeking after Forced Abstinence in Sprague-Dawley Rats 68
A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia 68
Use of phenylethanolaminotetralines for preparing anxiolytic drugs 68
Early Blockade of CB1 Receptors Ameliorates Schizophrenia-like Alterations in the Neurodevelopmental MAM Model of Schizophrenia 68
Prenatal Exposure to Δ9-Tetrahydrocannabinol Affects Hippocampus-Related Cognitive Functions in the Adolescent Rat Offspring: Focus on Specific Markers of Neuroplasticity 67
HDAC1 and HDAC3 underlie dynamic H3K9 acetylation during embryonic neurogenesis and in schizophrenia-like animals 67
Dual effects of melatonin on barbiturate-induced narcosis in rats 67
Biocompatibility of a genetically encoded calcium indicator in a transgenic mouse model 66
D3 dopamine receptor knockout mice: behavioral alteration in experimental models of anxiety 66
Extinction of avoidance behavior by safety learning depends on endocannabinoid signaling in the hippocampus 66
Cannabidiol and positive effects on object recognition memory in an in vivo model of Fragile X Syndrome: Obligatory role of hippocampal GPR55 receptors 65
Parkin expression profile in dopamine d3 receptor knock-out mice brains 64
Role of the endocannabinoid system and vanilloid TRPV1 channels in the phenotype of dopamine D3 receptor knock-out mice 63
Placebo affects the performance of rats in models of depression: is it a good control for behavioral experiments? 63
Endocannabinoid system and mood disorders: Priming a target for new therapies 63
Dysregulation of endocannabinoid system in schizophrenia: the potential role of cannabinoid 1 receptor altered gene expression 63
Involvement of NK2 receptors in experimental models of anxiety and depression under basal and stress-related conditions 63
Topically administered NOX4 inhibitor, GLX7013114, is efficacious in treating the early pathological events of diabetic retinopathy 62
Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms 62
Dopaminergic drugs may counteract behavioral and biochemical changes induced by models of brain injury 62
Endocannabinoid system in sexual motivational processes: Is it a novel therapeutic horizon? 62
The amnesic effects induced by β-amyloidfragment 1–42 involve cannabinoid neurotransmission in the brain 62
Vitamin D and depression in women: a mini-review 62
Increased sensitivity to antidepressants of D(3) dopamine receptor-deficient mice in the forced swim test (FST) 61
Dynamic DNA methylation programs persistent adverse effects of early-life stress 61
Suppression of Methamphetamine Self-Administration by Ketamine Pre-treatment Is Absent in the Methylazoxymethanol (MAM) Rat Model of Schizophrenia 60
Endocannabinoid system genes regulation in schizophrenia 60
Lack of interaction of endocannabinoids and 5-HT(3) neurotransmission in associative fear circuits of the amygdala: evidence from electrophysiological and behavioural experiments 60
Stressors affect the response of male and female rats to clomipramine in a model of behavioral despair (forced swim test) 60
Interacting effects of the MAM model of schizophrenia and antipsychotic treatment: Untargeted proteomics approach in adipose tissue 60
Binge-like alcohol exposure in adolescence: behavioural, neuroendocrine and molecular evidence of abnormal neuroplasticity … and return 60
Olanzapine, but not haloperidol, exerts pronounced acute metabolic effects in the methylazoxymethanol rat model 59
Increased levels of conditioned fear and avoidance behavior coincide with changes in phosphorylation of the protein kinase B (AKT) within the amygdala in a mouse model of extremes in trait anxiety 59
Nociceptin/orphanin FQ opioid receptor (NOP) selective ligand MCOPPB links anxiolytic and senolytic effects 59
DNA methylation at cannabinoid type 1 and dopamine D2 receptor genes in saliva samples of psychotic subjects: Is there an effect of Cannabis use? 58
Leading compounds for the validation of animal models of psychopathology 58
Prenatal influences facilitate the precipitation of a schizophrenia-like phenotype: assessing the role of the endocannabinoid system 58
Enhanced cognitive performance of dopamine D3 receptor "knock-out" mice in the step-through passive-avoidance test: assessing the role of the endocannabinoid/endovanilloid systems 58
The beta3 adrenoceptor agonist amibegron counteracts stress-induced behavioural and neurobiological changes 58
Hippocampal neuroplasticity is involved in the antidepressant-like effects of 5HT4 receptor partial agonist SL 65.0155 57
Signaling through cGMP-dependent protein kinase I in the amygdala is critical for auditory-cued fear memory and long-term potentiation 57
The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors. 57
Prolonged fear incubation leads to generalized avoidance behavior in mice 56
Endocannabinoid system, stress and HPA axis 56
Deficiency of histone variant macroH2A1.1 is associated with sexually dimorphic obesity in mice 55
Role of the Endocannabinoid System in Depression: from Preclinical to Clinical Evidence 55
Cognitive effects of SL650155, a 5HT4 receptor partial agonist, in animal models of amnesia 55
Memory performance of dopamine D3 knock-out mice (KO) mice pre-treated with beta-amyloid peptide is affected by cannabinoid CB1 receptor antagonist 54
Structural and behavioural changes in a rodent developmental disruption model of schizophrenia 54
Parkin expression in dopamine D3 receptor Knock out mice 52
Early pharmacological modulation of the endogenous cannabinoid signaling counteracts the phenotype in a rodent developmental disruption model of schizophrenia at adulthood 52
Metabolic profile of methylazoxymethanol model of schizophrenia in rats and effects of three antipsychotics in long-acting formulation 52
Use of phenylethanolaminotetralines for preparing anxiolytic drugs 50
Totale 7.393
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.609
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.609
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021305 0 0 0 0 134 9 64 6 21 7 44 20
2021/2022661 91 89 7 23 99 11 95 35 32 2 12 165
2022/20231.050 97 49 12 84 87 186 10 184 262 3 42 34
2023/2024444 31 67 26 32 18 53 4 14 34 17 92 56
2024/20252.327 30 334 127 119 575 352 41 82 162 178 145 182
2025/20262.101 285 192 774 311 539 0 0 0 0 0 0 0
Totale 7.743